Member

Georgia TRAMACERE

S&D · Italy

Group: S&D
Country: Italy
Roll-call participation: 89.0 %ⓘ of 2 244 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line: 95.9 %ⓘ of 1 998 votes where the group had a line · S&D median 96.3 %

More facts (5)

National party: PD Partito Democratico
In office: Since 11 Feb 2026
Against clear line: 59 of 1 950 votesⓘ
Committees: IMCO, ITRE (substitute), PETI, REGI (substitute)
Member id: 275087

National party: PD Partito Democratico
In office: Since 11 Feb 2026
Against clear line: 59 of 1 950 votesⓘ
Committees: IMCO, ITRE (substitute), PETI, REGI (substitute)
Member id: 275087

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes620 All roll calls5 928

Roll-call participation ⓘ

89.0 %

1 998 of 2 244 roll calls while in office

S&D median: 89.9 % (−0.8 pts)

Chamber median: 90.2 %

With majority line ⓘ

95.9 %

1 917 of 1 998 votes where their group had a line

S&D median: 96.3 % (−0.3 pts)

Against clear line ⓘ

3.0 %

59 of 1 950 votes where their group had a clear line

40 opposite (for ↔ against), 12 abstained against the line, 7 voted for or against when the line was to abstain

Abstention ⓘ

2.2 %

43 of 1 998 votes cast

Participation 89.0 % — S&D median 89.9 %, 138 members.ⓘ

Data as a table

Participation among the 138 members of the S&D with enough votes.
Figure	Participation
Georgia TRAMACERE	89.0 %
S&D median	89.9 %
Lowest in the group	30.4 %
Highest in the group	99.6 %
Members	138

With majority line 95.9 % — S&D median 96.3 %, 138 members.ⓘ

Data as a table

With majority line among the 138 members of the S&D with enough votes.
Figure	With majority line
Georgia TRAMACERE	95.9 %
S&D median	96.3 %
Lowest in the group	81.9 %
Highest in the group	99.4 %
Members	138

Whole term, 5 928 roll-call votes. The dots are the other members of S&D; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 2 244

Export

Every roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision and vote	Result	Position	Majority line
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2	406 for, 214 against, 29 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1	470 for, 117 against, 63 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3	334 for, 270 against, 34 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2	327 for, 272 against, 42 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1	433 for, 153 against, 53 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44	349 for, 228 against, 79 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2	340 for, 285 against, 24 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1	358 for, 210 against, 81 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41	362 for, 214 against, 75 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2	337 for, 303 against, 19 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1	532 for, 42 against, 82 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2	433 for, 135 against, 65 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1	548 for, 37 against, 60 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19	215 for, 294 against, 144 abstained	Position: Against	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19	278 for, 304 against, 69 abstained	Position: Against	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3	399 for, 182 against, 72 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2	299 for, 354 against, 6 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1	435 for, 197 against, 22 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4	353 for, 224 against, 63 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3	330 for, 256 against, 57 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2	339 for, 302 against, 12 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1	539 for, 20 against, 88 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3	388 for, 169 against, 88 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2	472 for, 133 against, 45 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1	501 for, 61 against, 74 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6	194 for, 309 against, 145 abstained	Position: Against	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5	342 for, 280 against, 30 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4	601 for, 46 against, 9 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2	490 for, 141 against, 26 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1	406 for, 200 against, 35 abstained	Position: For	Majority line: For
16 Sept 2026	An EU cardiovascular diseases strategy Final vote on the motion for a resolution	Adopted 545 for, 47 against, 75 abstained	Position: For	Majority line: For
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a whole	Adopted 470 for, 129 against, 62 abstained	Position: For	Majority line: For
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F	213 for, 426 against, 20 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64	218 for, 434 against, 4 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64	220 for, 432 against, 6 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64	175 for, 438 against, 50 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64	205 for, 442 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56	216 for, 439 against, 8 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35	231 for, 426 against, 9 abstained	Position: Against	Majority line: Against
16 Sept 2026	Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final vote	Passed 625 for, 20 against, 22 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decision	Consent given 612 for, 8 against, 16 abstained	Position: For	Majority line: For
16 Sept 2026	Instrument for Nuclear Safety Cooperation 2028-2034 Final vote	Passed 600 for, 21 against, 48 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decision	Consent given 631 for, 7 against, 15 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decision	Consent given 549 for, 75 against, 30 abstained	Position: For	Majority line: For
16 Sept 2026	EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decision	Consent given 640 for, 5 against, 26 abstained	Position: For	Majority line: For
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Final vote	Passed 496 for, 53 against, 125 abstained	Position: For	Majority line: For
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2	131 for, 532 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8	138 for, 532 against, 4 abstained	Position: Against	Majority line: Against
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1	168 for, 505 against, 4 abstained	Position: Against	Majority line: Against
16 Sept 2026	Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreement	Passed 530 for, 125 against, 12 abstained	Position: For	Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 8 of 29 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
11 Feb 2026	13	0
12 Feb 2026	141	0
24 Feb 2026	43	41
9 Mar 2026	1	0
10 Mar 2026	197	192
11 Mar 2026	60	60
12 Mar 2026	34	33
25 Mar 2026	3	3
26 Mar 2026	69	69
27 Apr 2026	2	0
28 Apr 2026	225	220
29 Apr 2026	296	292
30 Apr 2026	68	67
18 May 2026	4	0
19 May 2026	3	3
20 May 2026	96	95
21 May 2026	98	50
15 Jun 2026	2	0
16 Jun 2026	40	39
17 Jun 2026	127	120
18 Jun 2026	77	77
6 Jul 2026	2	0
7 Jul 2026	72	72
8 Jul 2026	144	144
9 Jul 2026	67	67
14 Sept 2026	1	0
15 Sept 2026	155	153
16 Sept 2026	80	79
17 Sept 2026	124	122

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Matteo RICCI	Matteo RICCI	S&D	Italy	99 % of 1 615 shared	93 %
Select Giuseppe LUPO	Giuseppe LUPO	S&D	Italy	98 % of 1 697 shared	93 %
Select Alessandra MORETTI	Alessandra MORETTI	S&D	Italy	98 % of 1 994 shared	93 %
Select Sandro RUOTOLO	Sandro RUOTOLO	S&D	Italy	98 % of 981 shared	93 %
Select Nicola ZINGARETTI	Nicola ZINGARETTI	S&D	Italy	98 % of 1 724 shared	93 %
Select Irene TINAGLI	Irene TINAGLI	S&D	Italy	98 % of 1 956 shared	93 %
Select Pierfrancesco MARAN	Pierfrancesco MARAN	S&D	Italy	98 % of 1 924 shared	93 %
Select Stefano BONACCINI	Stefano BONACCINI	S&D	Italy	98 % of 1 931 shared	93 %
Select Annalisa CORRADO	Annalisa CORRADO	S&D	Italy	98 % of 1 399 shared	93 %
Select Raffaele TOPO	Raffaele TOPO	S&D	Italy	97 % of 1 977 shared	93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Anna STÜRGKH	Anna STÜRGKH	Renew	Austria	90 % of 701 shared	86 %
Select Irena JOVEVA	Irena JOVEVA	Renew	Slovenia	90 % of 1 945 shared	86 %
Select Yvan VEROUGSTRAETE	Yvan VEROUGSTRAETE	Renew	Belgium	89 % of 1 820 shared	86 %
Select Pascal CANFIN	Pascal CANFIN	Renew	France	89 % of 1 785 shared	86 %
Select Valérie HAYER	Valérie HAYER	Renew	France	89 % of 1 915 shared	86 %
Select Anna-Maja HENRIKSSON	Anna-Maja HENRIKSSON	Renew	Finland	89 % of 1 799 shared	86 %
Select Marjan ŠAREC	Marjan ŠAREC	Renew	Slovenia	89 % of 1 838 shared	86 %
Select Elisabetta GUALMINI	Elisabetta GUALMINI changed group	Renew	Italy	89 % of 1 709 shared	86 %
Select Billy KELLEHER	Billy KELLEHER	Renew	Ireland	89 % of 1 986 shared	86 %
Select Martin HOJSÍK	Martin HOJSÍK	Renew	Slovakia	89 % of 1 896 shared	86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on the Internal Market and Consumer ProtectionIMCO Committee	Member	24 Feb 2026	now
Committee on Industry, Research and EnergyITRE Committee	Substitute	23 Feb 2026	now
Committee on PetitionsPETI Committee	Member	14 Sept 2026	now
Committee on Regional DevelopmentREGI Committee	Substitute	23 Feb 2026	now
Delegation to the EU-Albania Stabilisation and Association Parliamentary CommitteeD-AL Joint parliamentary committee	Member	9 Mar 2026	now
Delegation to the Parliamentary Assembly of the Union for the MediterraneanDMED Parliamentary assembly	Member	9 Mar 2026	now

Show all 6 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
No dossier named	Official delegation	ITRE	16 Sept 2026
Agreement, in the form of an Exchange of Letters, between the European Union and the Kingdom of Morocco amending and supplementing the Agreement for scientific and technological cooperation between the European Union and the Kingdom of Morocco setting out the terms and conditions for the participation of the Kingdom of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA)	Shadow rapporteur	ITRE	12 May 2026
Amending Directives 2009/43/EC and 2009/81/EC, as regards the simplification of intra-EU transfers of defence-related products and the simplification of security and defence procurement	Shadow rapporteur	IMCO	2 Mar 2026

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

4 contributions recorded; 4 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
15 Sept 2026	Acceleration of permit-granting for defence readiness projects (Omnibus V) - Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V) - Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V)	Speech · 1 min	Read
18 Jun 2026	Circularity requirements for vehicle design and management of end-of-life vehicles (debate)	Speech · 1 min	Read
19 May 2026	EU cybersecurity and preparedness in view of advanced AI systems (debate)	Speech · 1 min	Read
10 Mar 2026	Defence (joint debate)	Speech · 1 min	Read

Show all 4 recent contributions

Questions and motions, 15

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
7 Sept 2026	Extraterritorial impact of the US designation of Autistici/Inventati as a terrorist entity P-10-2026-003526	Priority written questionwith 28 co-authors	Not yet answered
1 Jul 2026	PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338	Motion for a resolutionwith 246 co-authors	—
24 Jun 2026	State of play of the EU authorisation procedure for concessions from social security contributions for large companies in Southern Italy (Italian Law No 207/2024). E-10-2026-002591	Written questionwith 4 co-authors	25 Aug 2026
10 Jun 2026	Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401	Priority written questionwith 37 co-authors	13 Aug 2026
9 Jun 2026	Protection of Italian citizen Nessy Guerra and her daughter, a minor, in Egypt E-10-2026-002377	Written questionwith 23 co-authors	7 Aug 2026
22 May 2026	The theme parks sector E-10-2026-002124	Written questionwith 3 co-authors	28 Jul 2026
19 May 2026	Employment conditions at the Italian National Institute of Astrophysics and protection of EU research funds E-10-2026-002070	Written questionwith 6 co-authors	3 Jul 2026
13 May 2026	Another shooting attack by Libyan militias on the humanitarian vessel Sea-Watch 5 E-10-2026-002019	Written questionwith 31 co-authors	10 Aug 2026
11 May 2026	The compatibility with EU law of the Italian 2026 Security Law’s video surveillance measure E-10-2026-001948	Written questionwith 15 co-authors	18 Sept 2026
21 Apr 2026	Customs practices related to products imported from illegal Israeli settlements in the OPTs E-10-2026-001633	Written questionwith 71 co-authors	16 Jul 2026

Show all 15 questions and motions

Amendments tabled in committee, 11

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005	CJ53	17
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932	CJ53	27
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933	CJ53	11
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934	CJ53	14
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935	CJ53	24
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936	CJ53	17
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937	CJ53	11
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938	CJ53	5
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939	CJ53	11
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953	CJ53	8

Show all 11 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group Progressive Alliance of Socialists and Democrats S&D · Centre-left · social democracy

National delegation

Delegation Italy National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/275087?page=4&rows=all&vscope=all
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “Georgia TRAMACERE”. Member record. memberId 275087. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/275087?page=4&rows=all&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/275087. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/275087?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-275087,
  author = {{EU Parl Watch Research}},
  title = {{Georgia TRAMACERE}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/275087?page=4&rows=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/275087?page=4&rows=all&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 275087. Official source: https://www.europarl.europa.eu/meps/en/275087. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}

Record

Votes, 2 244

Roll-call participation

Voting neighbours

Within S&D

Outside the group

Work

Seats

Dossiers

Topics they work on (model-assigned)

In the chamber

Questions and motions, 15

Amendments tabled in committee, 11

Connections

Political group

National delegation

Sources & citation

Cite as

Votes, 2 244